Clinical Trial Update: Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Thiotepa in Treating Patients With Non-malignant Disorders [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a donor stem cell transplant conditioning regimen with treosulfan, fludarabine, and thiotepa in patients with non-malignant he…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-malignant Hematopoietic and Lymphoid Cell Disorders

Drugs mentioned

• Fludarabine (Fludarabine)
• THIOTEPA (THIOTEPA)
• Treosulfan (treosulfan)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Non-Neoplastic Hematopoietic and Lymphoid Cell Disorder | Phase 2 | Status: RECRUITING